Gynaecological Cancers Risk : : Breast Cancer, Ovarian Cancer and Endometrial Cancer / / Ranjit Manchanda.
The International Agency for Research on Cancer suggests that the burden of women's cancers including breast, ovarian, and womb will rise by 50% over the next 20 years. It is essential for us to improve early diagnosis and prevention of these cancers in our health systems. The last decade has s...
Saved in:
VerfasserIn: | |
---|---|
Place / Publishing House: | Basel : : MDPI - Multidisciplinary Digital Publishing Institute,, 2022. |
Year of Publication: | 2022 |
Language: | English |
Physical Description: | 1 online resource (338 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993562237304498 |
---|---|
ctrlnum |
(CKB)4920000001372169 (NjHacI)994920000001372169 (EXLCZ)994920000001372169 |
collection |
bib_alma |
record_format |
marc |
spelling |
Manchanda, Ranjit, author. Gynaecological Cancers Risk : Breast Cancer, Ovarian Cancer and Endometrial Cancer / Ranjit Manchanda. Gynaecological Cancers Risk Basel : MDPI - Multidisciplinary Digital Publishing Institute, 2022. 1 online resource (338 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on publisher supplied metadata and other sources. The International Agency for Research on Cancer suggests that the burden of women's cancers including breast, ovarian, and womb will rise by 50% over the next 20 years. It is essential for us to improve early diagnosis and prevention of these cancers in our health systems. The last decade has seen significant strides in our ability to understand and predict a woman's risk of these cancers and offer personalized medicine approaches for risk management. There have been improvements in identifying individuals at increased risk, as well as implementing and evaluating strategies for screening and prevention. In this special collection, we bring together 16 articles from leading scientists and researchers. These capture some of the important advances observed in estimating cancer risk, providing genetic testing, offering risk management to those at increased risk, as well as screening and prevention of breast, ovarian, and womb cancers in women. This makes an important contribution to the rapidly advancing knowledge base across the area of personalized medicine and precision prevention of ovarian, endometrial, and breast cancers. Cancer Risk factors. Medicine, Preventive. Public health. 3-0365-2983-7 |
language |
English |
format |
eBook |
author |
Manchanda, Ranjit, |
spellingShingle |
Manchanda, Ranjit, Gynaecological Cancers Risk : Breast Cancer, Ovarian Cancer and Endometrial Cancer / |
author_facet |
Manchanda, Ranjit, |
author_variant |
r m rm |
author_role |
VerfasserIn |
author_sort |
Manchanda, Ranjit, |
title |
Gynaecological Cancers Risk : Breast Cancer, Ovarian Cancer and Endometrial Cancer / |
title_sub |
Breast Cancer, Ovarian Cancer and Endometrial Cancer / |
title_full |
Gynaecological Cancers Risk : Breast Cancer, Ovarian Cancer and Endometrial Cancer / Ranjit Manchanda. |
title_fullStr |
Gynaecological Cancers Risk : Breast Cancer, Ovarian Cancer and Endometrial Cancer / Ranjit Manchanda. |
title_full_unstemmed |
Gynaecological Cancers Risk : Breast Cancer, Ovarian Cancer and Endometrial Cancer / Ranjit Manchanda. |
title_auth |
Gynaecological Cancers Risk : Breast Cancer, Ovarian Cancer and Endometrial Cancer / |
title_alt |
Gynaecological Cancers Risk |
title_new |
Gynaecological Cancers Risk : |
title_sort |
gynaecological cancers risk : breast cancer, ovarian cancer and endometrial cancer / |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute, |
publishDate |
2022 |
physical |
1 online resource (338 pages) |
isbn |
3-0365-2983-7 |
callnumber-first |
R - Medicine |
callnumber-subject |
RC - Internal Medicine |
callnumber-label |
RC268 |
callnumber-sort |
RC 3268.48 M363 42022 |
illustrated |
Not Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
610 - Medicine & health |
dewey-ones |
616 - Diseases |
dewey-full |
616.994071 |
dewey-sort |
3616.994071 |
dewey-raw |
616.994071 |
dewey-search |
616.994071 |
work_keys_str_mv |
AT manchandaranjit gynaecologicalcancersriskbreastcancerovariancancerandendometrialcancer AT manchandaranjit gynaecologicalcancersrisk |
status_str |
n |
ids_txt_mv |
(CKB)4920000001372169 (NjHacI)994920000001372169 (EXLCZ)994920000001372169 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Gynaecological Cancers Risk : Breast Cancer, Ovarian Cancer and Endometrial Cancer / |
_version_ |
1764989440815529984 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02164nam a2200301 i 4500</leader><controlfield tag="001">993562237304498</controlfield><controlfield tag="005">20230223071809.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230223s2022 sz o 000 0 eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4920000001372169</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)994920000001372169</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994920000001372169</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC268.48</subfield><subfield code="b">.M363 2022</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.994071</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Manchanda, Ranjit,</subfield><subfield code="e">author.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Gynaecological Cancers Risk :</subfield><subfield code="b">Breast Cancer, Ovarian Cancer and Endometrial Cancer /</subfield><subfield code="c">Ranjit Manchanda.</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Gynaecological Cancers Risk </subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel :</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute,</subfield><subfield code="c">2022.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (338 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The International Agency for Research on Cancer suggests that the burden of women's cancers including breast, ovarian, and womb will rise by 50% over the next 20 years. It is essential for us to improve early diagnosis and prevention of these cancers in our health systems. The last decade has seen significant strides in our ability to understand and predict a woman's risk of these cancers and offer personalized medicine approaches for risk management. There have been improvements in identifying individuals at increased risk, as well as implementing and evaluating strategies for screening and prevention. In this special collection, we bring together 16 articles from leading scientists and researchers. These capture some of the important advances observed in estimating cancer risk, providing genetic testing, offering risk management to those at increased risk, as well as screening and prevention of breast, ovarian, and womb cancers in women. This makes an important contribution to the rapidly advancing knowledge base across the area of personalized medicine and precision prevention of ovarian, endometrial, and breast cancers.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cancer</subfield><subfield code="x">Risk factors.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medicine, Preventive.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Public health.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-2983-7</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-03-01 00:40:00 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-09-22 08:09:39 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338203510004498&Force_direct=true</subfield><subfield code="Z">5338203510004498</subfield><subfield code="8">5338203510004498</subfield></datafield></record></collection> |